Ropack Pharma Solutions has appointed Francois Chouinard as its new director of business development for research and development and formulation.
He will be responsible for the business development of the Long Island, New York drug development facilities at the contract development and manufacturing organisation (CDMO) / contract manufacturing organisation (CMO).
Chouinard brings over 20 years of experience in generic, contract development and biotech industries to the role, most recently serving as executive director of product development at Halo Pharmaceutical in Montreal, Canada.
He will report directly to Paul Dupont, vice president for marketing and business development at Canada-headquartered Ropack Pharma Solutions.
Dupont said: “Francois brings a deep understanding of the drug development process. His many years of success and experience working in the CDMO/CMO environment, are unique and valuable assets which will advance and support our mission to provide a superior customer engagement experience.”